1 1

FDA Drug Approval, ANDA 212025, APOMORPHINE HYDROCHLORIDE

FDA Drug Approval, ANDA 212025, APOMORPHINE HYDROCHLORIDE

$684.75 USD
$684.75 USD
Sale Sold out

Contents: CMC section from the Summary Basis of Approval; Clinical Review Summary; and Review Package including any evaluation of the product.

ANDA: 212025
Company: SAGE CHEMS
Drug Name: APOMORPHINE HYDROCHLORIDE
Active Ingredients: APOMORPHINE HYDROCHLORIDE
Strength: 30MG/3ML (10MG/ML)
Dosage Form/Route: INJECTABLE;SUBCUTANEOUS
Action Date: 02/23/2022
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AP

226 pages (32 of 258 original pages are fully redacted)
View full details
FOIA Pro

This drug has a lot more FDA history than one product page can show

FOIA Pro gives you full-text search across 70,000+ FDA FOIA records, from 2020 through today, plus a monthly monitor tracking new requests as they close.
  • Full-text search across every FDA FOIA log since 2020
  • Warning letters, approval records, and correspondence in one place
  • Monthly FDA FOIA Monitor newsletter, included
  • Cancel anytime, monthly or annual billing
Get FOIA Pro
Live search · FOIA database
Searching related FDA records…
ClosedTypeSubjectOutcome